Iovance Biotherapeutics, Inc. (IOVA) vs Legend Biotech Corporation Sponsored ADR (LEGN)
- Iovance Biotherapeutics, Inc. IOVA 7.99 +3.23%
- Legend Biotech Corporation Sponsored ADR LEGN 23.45 +4.04%
Iovance Biotherapeutics, Inc. and Legend Biotech Corporation Sponsored ADR are both Biotechnology companies. Legend Biotech Corporation Sponsored ADR is the larger, with a market value of $4.4B against $3.5B — 1.2× the size. Legend Biotech Corporation Sponsored ADR grew revenue faster over the last twelve months: 59.6% against 51.3%. Legend Biotech Corporation Sponsored ADR has the higher net margin (−7.20% vs −58.2%) and the higher return on invested capital (−9.54% vs −17.7%). Across the 17 metrics below, Legend Biotech Corporation Sponsored ADR leads on 13 and Iovance Biotherapeutics, Inc. on 4.
Valuation
Profitability
| Metric | IOVA | LEGN | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 56.58% | 68.51% |
| Operating margin | (60.79%) | (5.06%) | 0.00% |
| Net margin | (58.19%) | (7.20%) | 0.00% |
| Free cash flow margin | (57.01%) | (9.58%) | 0.00% |
| Return on equity | (29.11%) | (8.08%) | (51.96%) |
| Return on assets | (23.26%) | (5.32%) | (46.06%) |
| Return on invested capital | (17.72%) | (9.54%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack